Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ardagh in connection with the acquisition of Impress Metal Packaging
Mandate

Vinge advises Ardagh in connection with the acquisition of Impress Metal Packaging

December 09, 2010

Vinge has advised Ardagh Corporate Services Limited in connection with Ardagh Glass' acquisition of Impress Metal Packaging for approximately EUR 1.7 billion. 

Impress is a company with global operations in the metal packaging industry. Ardagh Glass is currently the third largest glass packaging supplier in Europe. Following the acquisition, the company will have 81 production facilities and enjoy a leading market position with sales of EUR 3 billion and 14,000 employees. The operations will be conducted under the name, Ardagh Packaging Group. The transaction is conditional uipon the requisite approvals from the European and US competition authorities.
 
Vinge's team consisted of Mikael Ståhl, Björn Gustavsson, Albert Wållgren, Elin Hjort, Andreas Malmberg and Christina O Rosén.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026